☰ Navigation Tabs
Solution NMR structure of farnesylated PEX19, C-terminal domain
NMR Experiment Experiment Type Sample Contents Solvent Ionic Strength pH Pressure Temperature (K) Spectrometer 1 3D HNCA 1 mM {U-1H,13C,15N; farnesyl-[1H,12C]} PEX19 90% H2O/10% D2O 50 mM 6.5 1 atm 298 Bruker AVANCE III 750 2 3D HNCACB 1 mM {U-1H,13C,15N; farnesyl-[1H,12C]} PEX19 90% H2O/10% D2O 50 mM 6.5 1 atm 298 Bruker AVANCE III 750 3 3D CBCA(CO)NH 1 mM {U-1H,13C,15N; farnesyl-[1H,12C]} PEX19 90% H2O/10% D2O 50 mM 6.5 1 atm 298 Bruker AVANCE III 750 4 3D HCCH-TOCSY 1 mM {U-1H,13C,15N; farnesyl-[1H,12C]} PEX19 90% H2O/10% D2O 50 mM 6.5 1 atm 298 Bruker AVANCE III 750 5 3D 1H-13C NOESY 1 mM {U-1H,13C,15N; farnesyl-[1H,12C]} PEX19 90% H2O/10% D2O 50 mM 6.5 1 atm 298 Bruker AVANCE 900 6 3D 1H-15N NOESY 1 mM {U-1H,13C,15N; farnesyl-[1H,12C]} PEX19 90% H2O/10% D2O 50 mM 6.5 1 atm 298 Bruker AVANCE 900
NMR Spectrometer Information Spectrometer Manufacturer Model Field Strength 1 Bruker AVANCE III 750 2 Bruker AVANCE 900
NMR Ensemble Information Conformer Selection Criteria Conformers Calculated Total Number Conformers Submitted Total Number 20
Computation: NMR Software # Classification Version Software Name Author 1 refinement CNS BRUNGER A. T. ET.AL.